Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X
about
Angiotensin II is involved in nitric oxide synthase and cyclo-oxygenase inhibition-induced leukocyte-endothelial cell interactions in vivoThe antihypertensive profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential homeostatic compensatory mechanisms in renal hypertensive ratsPharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtypeEffects of the angiotensin type I receptor antagonist, losartan, on systemic and regional vascular responses to lower body negative pressure in healthy volunteersEffects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.Could the pharmacological differences observed between angiotensin II antagonists and inhibitors of angiotensin converting enzyme be clinically beneficial?Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal massAT(1)-receptor blockade and sympathetic neurotransmission in cardiovascular disease.Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.A pharmacodynamic study of SR 47436, a selective AT1 receptor antagonist, on blood pressure in conscious cynomolgus monkeys.Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat.New insights into the role of aminopeptidases in the treatment for both preeclampsia and preterm labor.Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy.New therapeutic agents in the management of hypertension: angiotensin II-receptor antagonists and renin inhibitors.Cardiac haemodynamic effects of the non-peptide, angiotensin II-receptor antagonist, DuP 753, in conscious Long Evans and Brattleboro rats.Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans.Alterations of cyclo-oxygenase products and NO in responses to angiotensin II of resistance arteries from the spontaneously hypertensive rat.Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious ratsComparison of the regional haemodynamic effects of the AT1-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro ratsSympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats.Endogenous angiotensin II has fewer effects but neuronal nitric oxide synthase has excitatory effects on renal sympathetic nerve activity in salt-sensitive hypertension-induced heart failure.Effects of losartan on short-term variability of blood pressure in SHR and WKY rats.Role of the renin-angiotensin system in systemic and regional vascular responses to orthostatic stress in healthy volunteers.
P2860
Q28346472-347AE19F-231E-41A2-943A-D9EC9D7A152FQ28369423-5ABD6097-8031-48CF-A515-1B72A93660F4Q28378367-797C4F08-51B2-46CB-B2E9-4F9B4DD90B35Q34347645-9A841058-88EC-424A-8EAB-DBE6DA4FFDD5Q34481753-2873C9EF-FBC0-4785-B85B-37F13A6D47A7Q35555745-D6E4A2FA-FD92-4EEA-9B04-E4C015735750Q35821338-D0B5ADCF-CA3B-43F7-A5BF-A12D0AED42A4Q35837657-3FC5522B-5A8C-4465-BDC8-8267E49DF2D2Q35873111-BC9DB27B-3CCB-4D62-A504-52085198BB64Q35874306-BCB0D4E4-60C9-40A6-8828-8536A976D5FAQ35884801-B45C4A91-400D-414F-BF3B-F9485C79CC92Q38127847-8CA4E7DA-3575-453B-AD09-814431CB398FQ40811095-99F573DF-D9FE-4B6F-8BFD-2FF74F561CCDQ40813465-712D2771-8B06-4DBD-AF9E-44C82BC4AE7CQ41857844-2B38DFC9-A64C-44A3-9643-C5409145B4EAQ42084127-EDE457D2-CBF1-490C-9BB9-AADA20CA327AQ42581842-D4E1D8E2-270E-4427-9DBA-E169BD23DD40Q42702738-ED2034F9-9C22-4EC5-A76D-9BA0C6E81D6FQ42714643-EF393A8A-C6BD-41DB-8274-3D4255B4A19AQ44316799-3A5507D4-AA62-47ED-8A66-2E29D950077FQ46064511-A1CF0106-528A-44B2-A688-E1679BA7C118Q52359292-BBFBC366-F54B-4526-B7A3-71784ECDFEB2Q54184088-5585D0CE-112D-4BD4-BF6C-9E8352F1D090
P2860
Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X
description
1990 nî lūn-bûn
@nan
1990 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Hypotensive action of DuP 753, ...... sin II receptor antagonists: X
@ast
Hypotensive action of DuP 753, ...... sin II receptor antagonists: X
@en
Hypotensive action of DuP 753, ...... sin II receptor antagonists: X
@nl
type
label
Hypotensive action of DuP 753, ...... sin II receptor antagonists: X
@ast
Hypotensive action of DuP 753, ...... sin II receptor antagonists: X
@en
Hypotensive action of DuP 753, ...... sin II receptor antagonists: X
@nl
prefLabel
Hypotensive action of DuP 753, ...... sin II receptor antagonists: X
@ast
Hypotensive action of DuP 753, ...... sin II receptor antagonists: X
@en
Hypotensive action of DuP 753, ...... sin II receptor antagonists: X
@nl
P2093
P356
P1433
P1476
Hypotensive action of DuP 753, ...... sin II receptor antagonists: X
@en
P2093
A L Johnson
D J Carini
J V Duncia
P B Timmermans
R R Wexler
P304
P356
10.1161/01.HYP.15.5.459
P407
P577
1990-05-01T00:00:00Z